NASDAQ:ARCT | Market Exclusive

Home Tags NASDAQ:ARCT

Arcturus Therapeutics Ltd (NASDAQ:ARCT) has coverage initiated with a Buy rating...

ME Staff - April 5, 2019 0

Arcturus Therapeutics Ltd (NASDAQ:ARCT) had its Buy rating reiterated by Chardan...

ME Staff - March 19, 2019 0

Arcturus Therapeutics Ltd (NASDAQ:ARCT) has coverage initiated with a Buy rating

ME Staff - February 19, 2019 0

Arcturus Therapeutics Ltd (NASDAQ:ARCT) gets upgraded to Strong-Buy by WBB Securities

ME Staff - September 20, 2018 0

Analyst Upgrades – NASDAQ:ARCT – Arcturus Therapeutics (NASDAQ:ARCT) Stock Gets Upgraded...

ME Staff - June 11, 2018 0

Analyst Downgrades – Arcturus Therapeutics (NASDAQ:ARCT) Stock Gets Downgraded By Ladenburg...

ME Staff - February 28, 2018 0

Analyst Activity – Chardan Capital Initiates Coverage On Arcturus Therapeutics (NASDAQ:ARCT)...

ME Staff - January 22, 2018 0

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 24, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 18, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

November 10, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: NASDAQ:ARCT

Arcturus Therapeutics Ltd (NASDAQ:ARCT) has coverage initiated with a Buy rating...

Arcturus Therapeutics Ltd (NASDAQ:ARCT) had its Buy rating reiterated by Chardan...

Arcturus Therapeutics Ltd (NASDAQ:ARCT) has coverage initiated with a Buy rating

Arcturus Therapeutics Ltd (NASDAQ:ARCT) gets upgraded to Strong-Buy by WBB Securities

Analyst Upgrades – NASDAQ:ARCT – Arcturus Therapeutics (NASDAQ:ARCT) Stock Gets Upgraded...

Analyst Downgrades – Arcturus Therapeutics (NASDAQ:ARCT) Stock Gets Downgraded By Ladenburg...

Analyst Activity – Chardan Capital Initiates Coverage On Arcturus Therapeutics (NASDAQ:ARCT)...

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY